Alkeon Capital Management LLC Morphic Holding, Inc. Transaction History

Alkeon Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$43.27 - $65.72 $16.9 Million - $25.7 Million	-391,452 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$53.61 - $67.5 $29,378 - $36,990	-548 Reduced 0.14%	391,452 $22.2 Million
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $7.2 Million - $20.5 Million	242,000 Added 161.33%	392,000 $24.8 Million
Q3 2020 Nov 16, 2020	BUY	$22.51 - $30.11 $1.13 Million - $1.51 Million	50,000 Added 50.0%	150,000 $4.1 Million
Q2 2020 Aug 14, 2020	BUY	$12.65 - $29.57 $1.27 Million - $2.96 Million	100,000 New	100,000 $2.71 Million

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.